Jessica Cini, Translational Medicine Alliance, 866-831-3243, email@example.com
A biomedical industry collaboration for innovation
(KANSAS CITY, Mo.) July 21, 2010— The Translational Medicine Alliance Forum will convene October 13–14, 2010 at the Mandarin Oriental in Washington, DC. This year’s Forum will be hosted by three organizations with the common interest of accelerating translational research to the patient.
The Forum brings together leaders from academia, government agencies, and pharmaceutical, biotechnology and venture industries to work toward developing a deeper understanding of effective models to enable and accelerate the progress of translational medicine. Through focused, dynamic sessions and exclusive networking opportunities, attendees have the opportunity to learn about breakthrough approaches and progress on current best practices in translational medicine collaborations.
"Translational medicine holds some of the most promising advancements, and through this Forum, we are able to help facilitate and encourage a steady pathway to success for current and future research," said Lesa Mitchell, vice president of Advancing Innovation, Ewing Marion Kauffman Foundation. The Kauffman Foundation helped found the Translational Medicine Alliance in 2007.
This Forum will focus on the following topics: regulatory science, lessons from the most experienced translational models, how and why rare disease and pediatric medicine are changing the landscape, transparency and access to data and reverse engineering translational science starting with the patient.
The 2010 Forum is cosponsored by the Ewing Marion Kauffman Foundation, FasterCures and the Council for American Innovation. Registration for the Forum is now open. Early bird rates are available now through August 16, 2010, with a rate of $595 for corporate and $200 for academic and not-for-profit registrations. Space is limited. To register for the Forum, visit www.regonline.com/2010_translational_medicine_alliance_forum or call 866-831-3243.
Translational Medicine Alliance
The TransMed Partnership was formed in March 2007 to tap into the best ideas of thought leaders and develop an integrated strategy to support and advance the most promising technologies. The Alliance was founded by the Kauffman Foundation, Pfizer, Johnson and Johnson, Biogen Idec, FasterCures, Washington University, St. Louis (WUSTL) School of Medicine, BioVentures for Global Health, the Center for Emerging Technologies, BIOCOM, BIOTECanada, and LifeTech Innovations. For more information about the Alliance, please visit www.translationalmedicinealliance.org.